The fifth round of the Global Reproductive, Maternal, Newborn, Child and Adolescent Health Policy Survey was conducted in 2018-2019. For this survey, the questionnaire was administered online to each member state via World Health Organization (WHO) regional offices. Each WHO country office was asked to coordinate completion of the survey with the Ministry of Health and other UN partners. Respondents from each country shared original source documents including national policies, strategies, laws, guidelines, reports that are relevant to the areas of sexual and reproductive health, maternal and newborn health, child health, adolescent health, gender-based violence and cross-cutting issues. Cross cutting issues include policies, guidelines and legislation for human right to healthcare, financial protection, and quality of care.The WHO cross-cutting issues page can be found here, and the WHO data can also be accessed on their data portal page, here. Adolescent Health Policy data, provided by the WHO, show the below data attributes for countries that have an International Confederation of Midwives (ICM) membership and have completed the required surveys. Academia typically included in the RMNCAH coordinating body Adolescents/young people typically included in the RMNCAH coordinating body Civil society typically included in the RMNCAH coordinating body Donors typically included in the RMNCAH coordinating body Engagement of civil society in review of national RMNCAH programmes H6 partnership organizations typically included in the RMNCAH coordinating body Law requiring birth registration Law requiring death registration Ministry of Health typically included in the RMNCAH coordinating body National human rights institution considers RMNCAH issues National law guarantees universal access to primary health care National policy on Quality of Care for health services exists National policy on Quality of Care includes Adolescent health National policy on Quality of Care includes Maternal health National policy on Quality of Care includes Newborn health National policy on Quality of Care includes Sexual and reproductive health National policy to ensure engagement of civil society organisation representatives in national level planning of RMNCAH programmes National RMNCAH coordinating body Non-health government sectors typically included in the RMNCAH coordinating body Private sector typically included in the RMNCAH coordinating body Professional associations typically included in the RMNCAH coordinating body This data set is just one of the many datasets on the Global Midwives Hub, a digital resource with open data, maps, and mapping applications (among other things), to support advocacy for improved maternal and newborn services, supported by the International Confederation of Midwives (ICM), UNFPA, WHO, and Direct Relief.

The fifth round of the Global Reproductive, Maternal, Newborn, Child and Adolescent Health Policy Survey was conducted in 2018-2019. For this survey, the questionnaire was administered online to each member state via World Health Organization (WHO) regional offices. Each WHO country office was asked to coordinate completion of the survey with the Ministry of Health and other UN partners. Respondents from each country shared original source documents including national policies, strategies, laws, guidelines, reports that are relevant to the areas of sexual and reproductive health, maternal and newborn health, child health, adolescent health, gender-based violence and cross-cutting issues. Cross cutting issues include policies, guidelines and legislation for human right to healthcare, financial protection, and quality of care.The WHO Maternal and Newborn Health page can be found here, and the WHO data can also be accessed on their data portal page, here. Maternal and Newborn Health Policy data, provided by the WHO, show the below data attributes for countries that have an International Confederation of Midwives (ICM) membership and have completed the required surveys. Essential Medicines List Includes: Magnesium sulfate for use during pregnancy, childbirth and postpartum careOxytocin for use during pregnancy, childbirth and postpartum careMisoprostol tablets for use during pregnancy, childbirth and postpartum careAmpicillin or Amoxicillin injections for use during pregnancy, childbirth and postpartum careGentamicin injectionMetronidazole injectionProcaine penicillin injectionBenzathine penicillin injectionDexamethasone injectionChlorhexidineCeftriaxoneIntravenous tranexamic acidNational list of Commodities Includes:Obstetric ultrasound machineSelf-inflating bag with neonatal and paediatric masks of different sizes and valves Oxygen supplyVaccuum aspiratorHealth Access Policy: User fee exemptions for antenatal care services for women of reproductive ageUser fee exemptions for normal childbirth services for women of reproductive ageUser fee exemptions for postnatal care for mothersUser fee exemptions for postnatal care for newbornsMaternal and Newborn Health Policies: Policy/legislation on free access to health services for newborns (0-4 weeks)Policy on free access to health services for pregnant womenNational policy on childbirthNational policy/guideline on right of every women to have access to skilled care at childbirthNational policy on postnatal care for mothers and newbornsNational policy on management of low birth weight and preterm newbornsNational standards for management of newborn infants with severe illnessContinuous professional education system in place for primary health-care clinicians and/or nurses to receive specific training for maternal and newborn healthNational policy on regulation of midwifery care providers based on ICMNational policy recommending midwife-led care for pregnancyNational policy recommending midwife-led care for childbirthNational policy recommending midwife-led care for the postnatal periodNational policy/law on maternal death notification within 24 hoursNational policy/law on maternal death reviewNational panel to review maternal deathsFrequency of meetings of national panel to review maternal deathsNational policy/law to review stillbirthsFacility stillbirth review process in placeNational policy/law to review neonatal deathsFacility neonatal death review process in placeThis data set is just one of the many datasets on the Global Midwives Hub, a digital resource with open data, maps, and mapping applications (among other things), to support advocacy for improved maternal and newborn services, supported by the International Confederation of Midwives (ICM), UNFPA, WHO, and Direct Relief.

Integrated Geodatabase: The Global Catholic Foortprint of Healthcare and WelfareBurhans, Molly A., Mrowczynski, Jon M., Schweigel, Tayler C., and Burhans, Debra T., Wacta, Christine. The Catholic Foortprint of Care Around the World (1). GoodLands and GHR Foundation, 2019.WHO Statistics Numbers:Clean Care is Safe Care, Registration Update. (2017). Retrieved n.d., from https://www.who.int/gpsc/5may/registration_update/en/.https://www.who.int/gpsc/5may/registration_update/en/Catholic Statistics Numbers:Annuarium Statisticum Ecclesiae – Statistical Yearbook of the Church: 1980 – 2018. LIBRERIA EDITRICE VATICAN.Historical Country Boundary Geodatabase:Weidmann, Nils B., Doreen Kuse, and Kristian Skrede Gleditsch. The Geography of the International System: The CShapes Dataset. International Interactions 36 (1). 2010.https://www.tandfonline.com/doi/full/10.1080/03050620903554614GoodLands created a significant new data set for GHR and the UISG of important Church information regarding orphanages and sisters around the world as well as healthcare, welfare, and other child care institutions. The data were extracted from the gold standard of Church data, the Annuarium Statisticum Ecclesiae, published yearly by the Vatican. It is inevitable that raw data sources will contain errors. GoodLands and its partners are not responsible for misinformation within Vatican documents. We encourage error reporting to us at data@good-lands.org or directly to the Vatican.GoodLands worked with the GHR Foundation to map Catholic Healthcare and Welfare around the world using data mined from the Annuarium Statisticum Eccleasiea. GHR supported the data development and GoodLands independently invested in the mapping of information.The workflows and data models developed for this project can be used to map any global, historical country-scale data in a time-series map while accounting for country boundary changes. GoodLands created proprietary software that enables mining the Annuarium Statisticum Eccleasiea (see Software and Program Library at our home page for details).The GHR Foundation supported data extraction and cleaning of this information.GoodLands’ supported the development of maps, infographics, and applications for all healthcare data.

The fifth round of the Global Reproductive, Maternal, Newborn, Child and Adolescent Health Policy Survey was conducted in 2018-2019. For this survey, the questionnaire was administered online to each member state via World Health Organization (WHO) regional offices. Each WHO country office was asked to coordinate completion of the survey with the Ministry of Health and other UN partners. Respondents from each country shared original source documents including national policies, strategies, laws, guidelines, reports that are relevant to the areas of sexual and reproductive health, maternal and newborn health, child health, adolescent health, gender-based violence and cross-cutting issues. Cross cutting issues include policies, guidelines and legislation for human right to healthcare, financial protection, and quality of care.Adolescent Health Policy data provided by the WHO show the below data attributes for countries that have an International Confederation of Midwives (ICM) membership, and can be found for all countries on the WHO website for Adolescent Health, here. Legal age for unmarried adolescents to provide consent for contraceptive services (except sterilization) without parental/legal guardian consentLegal age for unmarried adolescents to provide consent for emergency contraception without parental/legal guardian consentLegal age for unmarried adolescents to provide consent for HIV testing and counseling without parental/legal guardian consentLegal age for unmarried adolescents to provide consent for HIV care and treatment without parental/legal guardian consentLegal age for married adolescents to provide consent for contraceptive services (except sterilization) without spousal consentLegal age for married adolescents to provide consent for emergency contraception without spousal consentLegal age for married adolescents to provide consent for HIV testing and counseling without spousal consentLegal age for married adolescents to provide consent for HIV care and treatment without spousal consentNational policy/law to punish perpetrators of coerced sex involving adolescent girlsUser fee exemptions for HIV testing and counselling for adolescentsUser fee exemptions for contraceptives for adolescentsUser fee exemptions for testing and treatment of sexually transmitted infections for adolescentsUser fee exemptions for vaccination for HPV for adolescentsThis data set is just one of the many datasets on the Global Midwives Hub, a digital resource with open data, maps, and mapping applications (among other things), to support advocacy for improved maternal and newborn services, supported by the International Confederation of Midwives (ICM), UNFPA, WHO, and Direct Relief.

Less than 40 percent of ministries of health worldwide are led by women, indicating that women are underrepresented in the upper levels of management, leadership and governance in the health workforce. This statistic shows the percentage of World Health Organization Member State ministries of health headed by women in 2018, by region.

Results of screening of patients for common non-communicable diseases and their risk factors in 20 townships of Myanmar under the PEN project from May 2017-December 2018.

In 2023, Singapore dominated the ranking of the world's health and health systems, followed by Japan and South Korea. The health index score is calculated by evaluating various indicators that assess the health of the population, and access to the services required to sustain good health, including health outcomes, health systems, sickness and risk factors, and mortality rates. The health and health system index score of the top ten countries with the best healthcare system in the world ranged between 82 and 86.9, measured on a scale of zero to 100.

Global Health Security Index  Numerous health and health system indexes have been developed to assess various attributes and aspects of a nation's healthcare system. One such measure is the Global Health Security (GHS) index. This index evaluates the ability of 195 nations to identify, assess, and mitigate biological hazards in addition to political and socioeconomic concerns, the quality of their healthcare systems, and their compliance with international finance and standards. In 2021, the United States was ranked at the top of the GHS index, but due to multiple reasons, the U.S. government failed to effectively manage the COVID-19 pandemic. The GHS Index evaluates capability and identifies preparation gaps; nevertheless, it cannot predict a nation's resource allocation in case of a public health emergency.

Universal Health Coverage Index  Another health index that is used globally by the members of the United Nations (UN) is the universal health care (UHC) service coverage index. The UHC index monitors the country's progress related to the sustainable developmental goal (SDG) number three. The UHC service coverage index tracks 14 indicators related to reproductive, maternal, newborn, and child health, infectious diseases, non-communicable diseases, service capacity, and access to care. The main target of universal health coverage is to ensure that no one is denied access to essential medical services due to financial hardships. In 2021, the UHC index scores ranged from as low as 21 to a high score of 91 across 194 countries. 

This statistic shows the perceived and actual number of infants who had all the recommended World Health Organization vaccinations in 2018, by country. During the survey, respondents were asked to estimate how many infants out of 100 had all the recommended vaccinations for diphtheria, tetanus, whooping cough, polio, and measles in their country. According to data from IPSOS, respondents from the United States estimated that 75 out of 100 infants had all the recommended vaccinations. 95 out of 100 infants in the U.S. had all the recommended WHO vaccinations.

The fifth round of the Global Reproductive, Maternal, Newborn, Child and Adolescent Health Policy Survey was conducted in 2018-2019. For this survey, the questionnaire was administered online to each member state via World Health Organization (WHO) regional offices. Each WHO country office was asked to coordinate completion of the survey with the Ministry of Health and other UN partners. Respondents from each country shared original source documents including national policies, strategies, laws, guidelines, reports that are relevant to the areas of sexual and reproductive health, maternal and newborn health, child health, adolescent health, gender-based violence and cross-cutting issues. Cross cutting issues include policies, guidelines and legislation for human right to healthcare, financial protection, and quality of care.Adolescent Health Policy data provided by the WHO show the below data attributes for countries that have an International Confederation of Midwives (ICM) membership, and can be found for all countries on the WHO website for Adolescent Health, here. Legal age for unmarried adolescents to provide consent for contraceptive services (except sterilization) without parental/legal guardian consentLegal age for unmarried adolescents to provide consent for emergency contraception without parental/legal guardian consentLegal age for unmarried adolescents to provide consent for HIV testing and counseling without parental/legal guardian consentLegal age for unmarried adolescents to provide consent for HIV care and treatment without parental/legal guardian consentLegal age for married adolescents to provide consent for contraceptive services (except sterilization) without spousal consentLegal age for married adolescents to provide consent for emergency contraception without spousal consentLegal age for married adolescents to provide consent for HIV testing and counseling without spousal consentLegal age for married adolescents to provide consent for HIV care and treatment without spousal consentNational policy/law to punish perpetrators of coerced sex involving adolescent girlsUser fee exemptions for HIV testing and counselling for adolescentsUser fee exemptions for contraceptives for adolescentsUser fee exemptions for testing and treatment of sexually transmitted infections for adolescentsUser fee exemptions for vaccination for HPV for adolescentsThis data set is just one of the many datasets on the Global Midwives Hub, a digital resource with open data, maps, and mapping applications (among other things), to support advocacy for improved maternal and newborn services, supported by the International Confederation of Midwives (ICM), UNFPA, WHO, and Direct Relief.

Layers

Data extracted from GBD Study [40, 41].

Abstract

The GYTS is a school-based survey which uses a self-administered questionnaire to monitor tobacco use among youth and to guide the implementation and evaluation of tobacco prevention and control programmes.

Geographic coverage

National

Analysis unit

Individuals

Universe

School-going adolescents aged 13-15 years.

Kind of data

Sample survey data [ssd]

Sampling procedure

GYTS uses a global standardized methodology that includes a two-stage sample design with schools selected with a probability proportional to enrollment size. The classes within selected schools are chosen randomly and all students in selected classes are eligible to participate in the survey.

A total of 2,071 eligible students in grades 7-9 completed the survey, of which 1,608 were aged 13-15 years.

Mode of data collection

self-administered

Cleaning operations

All data processing (scanning, cleaning, editing, and weighting) was conducted at the US Centers for Disease Control.

Response rate

The overall response rate was 89.0%.

Monaco MC: External Health Expenditure Per Capita: Current PPP data was reported at 0.000 Intl $ mn in 2018. This stayed constant from the previous number of 0.000 Intl $ mn for 2017. Monaco MC: External Health Expenditure Per Capita: Current PPP data is updated yearly, averaging 0.000 Intl $ mn from Dec 2000 (Median) to 2018, with 19 observations. The data reached an all-time high of 0.000 Intl $ mn in 2018 and a record low of 0.000 Intl $ mn in 2018. Monaco MC: External Health Expenditure Per Capita: Current PPP data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Monaco – Table MC.World Bank.WDI: Social: Health Statistics. Current external expenditures on health per capita expressed in international dollars at purchasing power parity. External sources are composed of direct foreign transfers and foreign transfers distributed by government encompassing all financial inflows into the national health system from outside the country.;World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database). The data was retrieved on April 15, 2024.;Weighted average;

Source: MINISTRY OF HEALTH

Data Last Updated: 26/08/2024

Update Frequency: Annual

Footnotes: Data are available from 2018 onwards based on the State Party Self-Assessment Annual Reporting Tool (SPAR) developed by World Health Organisation (WHO), as part of WHO's International Health Regulations (IHR) Monitoring and Evaluation Framework. Data are used for SDG 3.d.1 'International Health Regulations (IHR) capacity and health emergency preparedness'. Please refer to the Sustainable Development Goals (SDG) Global Metadata (https://unstats.un.org/sdgs/metadata) for more information on SDG 3.d.1.

Adapted from: https://tablebuilder.singstat.gov.sg/table/TS/M870511

The file contains population data for each country that we have studied. The 2018 population data were used in combination with the data of χ2 to calculate the fraction of COVID-19 cases per country. The file was obtained from the World Bank data repository [22]. (CSV)

Monaco MC: External Health Expenditure Per Capita: Current Price data was reported at 0.000 USD mn in 2018. This stayed constant from the previous number of 0.000 USD mn for 2017. Monaco MC: External Health Expenditure Per Capita: Current Price data is updated yearly, averaging 0.000 USD mn from Dec 2000 (Median) to 2018, with 19 observations. The data reached an all-time high of 0.000 USD mn in 2018 and a record low of 0.000 USD mn in 2018. Monaco MC: External Health Expenditure Per Capita: Current Price data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Monaco – Table MC.World Bank.WDI: Social: Health Statistics. Current external expenditures on health per capita expressed in current US dollars. External sources are composed of direct foreign transfers and foreign transfers distributed by government encompassing all financial inflows into the national health system from outside the country.;World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database). The data was retrieved on April 15, 2024.;Weighted average;

WHO Activity File - Qatar-2018-19

Germany DE: External Health Expenditure Per Capita: Current Price data was reported at 0.000 USD mn in 2018. This stayed constant from the previous number of 0.000 USD mn for 2017. Germany DE: External Health Expenditure Per Capita: Current Price data is updated yearly, averaging 0.000 USD mn from Dec 2000 (Median) to 2018, with 19 observations. The data reached an all-time high of 0.000 USD mn in 2018 and a record low of 0.000 USD mn in 2018. Germany DE: External Health Expenditure Per Capita: Current Price data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Germany – Table DE.World Bank.WDI: Social: Health Statistics. Current external expenditures on health per capita expressed in current US dollars. External sources are composed of direct foreign transfers and foreign transfers distributed by government encompassing all financial inflows into the national health system from outside the country.;World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database). The data was retrieved on April 15, 2024.;Weighted average;

Snapshot img

Infectious Disease Diagnostics Market Size 2024-2028

The infectious disease diagnostics market size is forecast to increase by USD 8.90 billion at a CAGR of 4.5% between 2023 and 2028. The market is witnessing substantial growth, driven by several key factors. The increasing prevalence of infectious diseases worldwide continues to fuel market expansion. According to the World Health Organization, infectious diseases account for approximately 15 million deaths annually, making them a significant global health concern. Moreover, the development of novel drugs and treatments is another significant growth driver. These advancements offer improved diagnostic accuracy and effectiveness, addressing the unmet needs of healthcare providers and patients. Additionally, the increasing adoption of Point-of-Care (POC) diagnostics is transforming the market landscape. POC testing enables rapid, on-site diagnosis, providing immediate results and improving patient outcomes. This trend is particularly prominent in resource-limited settings and emergency care, where quick diagnosis is crucial. The market's growth is further influenced by a transition towards more efficient systems, better accessibility, and higher industry standards. As the demand for advanced solutions grows, companies in this sector are prioritizing sustainability and operational efficiency to maintain a competitive edge.

What will be the size of the market during the forecast period?

Request Free Sample

Infectious Disease Diagnostics Market Segmentation

The infectious disease diagnostics market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

End-user

  Hospitals
  Labs


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

Which is the largest segment driving market growth?

The hospitals segment is estimated to witness significant growth during the forecast period.

The market is experiencing substantial growth due to the rising prevalence of diseases such as HIV, tuberculosis (TB), hepatitis, sexually transmitted infections (STIs), respiratory infections, and other infectious diseases. According to the World Health Organization, there are approximately 50,733 hospitals worldwide, and the number continues to grow. Hospitals procure medical testing kits, consumables, software, and services in large quantities from suppliers and group purchasing organizations (GPOs), driving market expansion. Clinical laboratories and urgent care centers are significant consumers of infectious disease diagnostic tools, with skilled technicians and physicians performing tests on samples such as blood, urine, mucus, and respiratory secretions.

Infectious diseases, including HIV, pneumonia, and hospital-acquired infections, require prompt diagnosis and infection control measures to prevent cross contamination and ensure personal health. Technological advancements in next-generation sequencing, genomic testing, molecular testing, and immunodiagnostics are enhancing pathogen detection capabilities, enabling rapid results and reducing false negatives and positives. The market encompasses a range of diagnostic devices, assays and reagents, and information technology systems, catering to various applications, including chest X-rays, CT scans, physical exams, and PCR testing. Infections caused by bacteria, viruses, fungi, and parasites continue to pose significant health risks, necessitating ongoing research and development In the market.

Get a glance at the market share of various regions. Download the PDF Sample

The Hospitals segment was valued at USD 23.83 billion in 2018 and showed a gradual increase during the forecast period.

Which region is leading the market?

Asia is estimated to contribute 43% to the growth of the global market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.The market in North America is driven by the increasing prevalence of infectious diseases, including HIV, tuberculosis (TB), hepatitis, sexually transmitted infections (STIs), and respiratory infections. According to the Centers for Disease Control and Prevention (CDC), respiratory tract infections caused by bacteria are among the most common conditions, affecting approximately 85 million Americans each year. These infections result in significant economic burden due to healthcare costs and lost productivity. In the US, infectious diseases such as AIDS, TB, meningitis, influenza, and pneumonia are major health concerns. The market growth is further fueled by the need for prompt

Effective coverage is defined as a national coverage of over 75%. *Armenia will be removed from the list of STH-endemic countries as of 2019 following results of recent surveys documenting extremely low prevalence and infection intensity.

Data extracted from GLOBOCAN 2018 [4].